Kamar Aulakh joins Velos
This article was originally published in Scrip
Velos (US), a clinical trial management resource for investigators, sponsors and academic leaders, has named Kamar Aulakh chief operating officer. He was previously president and CEO of Quark, a developer of software solutions for publishers. He has also held positions in Fortune 500 companies working in the telecommunications, energy and healthcare sectors.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.